On the other hand, increased oxidative stress may induce de novo lipogenesis through upregulation of sterol regulatory element-binding protein-1 (SREBP-1) and mitochondrial dysfunction in MASLD patients [76,77]. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.